First Tracks Biotherapeutics, Inc.

First Tracks Biotherapeutics, Inc. financial statements

First Tracks Biotherapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

Net income−USD 166.09MEODHD
Cash and equivalentsUSD 238.2MEODHD
Total debtUSD 14.11MEODHD

First Tracks Biotherapeutics, Inc. financials on 6ix · First Tracks Biotherapeutics, Inc. on 6ix